Novel modified nucleic acid sequences and methods for increasing mRNA levels and protein expression in cell systems

a cell system and protein technology, applied in the field of heterologous gene expression, can solve the problems of difficult recombinant production of certain heterologous gene products, difficult to express proteins derived from bacteria, parasites and viruses in cell culture systems different from the cell from which the protein was originally derived, and serious malaria problems, and achieve the effect of enhancing the expression of sufficient quantities

Inactive Publication Date: 2005-03-31
CHEN LI +1
View PDF18 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0008] The present invention provides improved recombinant DNA compositions and procedures for increasing the mRNA levels and protein expression of proteins derived from heterologous cells, preferably those of lower organisms such as bacteria, virus, and parasite, which have previously been difficult to express in cell culture systems, mammalian cell culture systems, or in transgenic mammals. The preferred protein candidates for expression in an expression system in accordance with the invention are those proteins having DNA coding sequences comprising high overall AT content or AT rich regions, and / or mRNA instability motifs and / or rare codons relative to the recombinant expression systems.

Problems solved by technology

Recombinant production of certain heterologous gene products is often difficult in in vitro cell culture systems or in vivo recombinant production systems.
For example, many researchers have found it difficult to express proteins derived from bacteria, parasites and virus in cell culture systems different from the cell from which the protein was originally derived, and particularly in mammalian cell culture systems.
Malaria is a serious heath problem in tropical countries.
However, a major problem in developing MSP-1 as a vaccine is the difficulty in obtaining recombinant proteins in bacterial or yeast expression systems that are equivalent in immunological potency to the affinity purified native protein (Chang et al., (1992) J. Immunol. 148:548-555.) and in large enough quantities to make vaccine production feasible.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel modified nucleic acid sequences and methods for increasing mRNA levels and protein expression in cell systems
  • Novel modified nucleic acid sequences and methods for increasing mRNA levels and protein expression in cell systems
  • Novel modified nucleic acid sequences and methods for increasing mRNA levels and protein expression in cell systems

Examples

Experimental program
Comparison scheme
Effect test

examples

[0048] Creation of Novel Modified MSP-142 Gene

[0049] In one embodiment, a novel modified nucleic acid encoding the C-terminal fragment of MSP-1 is provided. The novel, modified nucleic acid of the invention encoding a 42 kD C-terminal part of MSP-1 (MSP-142) capable of expression in mammalian cells of the invention is shown in FIG. 1. The natural MSP-142 gene (FIG. 2) was not capable of being expressed in mammalian cell culture or in transgenic mice Analysis of the natural MSP-142 gene suggested several characteristics that distinguish it from mammalian genes. First, it has a very high overall AT content of 76%. Second, the mRNA instability motif, AUUUA, occurred 10 times in this 1100 bp DNA segment (FIG. 2). To address these differences a new MSP-142 gene was designed. Silent nucleotide substitution was introduced into the native MSP-142 gene at 306 positions to reduce the overall AT content to 49.7%. Each of the 10 AUUUA mRNA instability motifs in the natural gene were eliminated...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
ionic strengthaaaaaaaaaa
ionic strengthaaaaaaaaaa
concentrationaaaaaaaaaa
Login to view more

Abstract

The invention provides modified recombinant nucleic acid sequences (preferably DNA) and methods for increasing the mRNA levels and protein expression of proteins which are known to be, or are likely to be, difficult to express in cell culture systems, mammalian cell culture systems, or in transgenic animals. The preferred “difficult” protein candidates for expression using the recombinant techniques of the invention are those proteins derived from heterologous cells preferably those of lower organisms such as parasites, bacteria, and virus, having DNA coding sequences comprising high overall AT content or AT rich regions and / or mRNA instability motifs and / or rare codons relative to the recombinant expression system to be used.

Description

BACKGROUND OF THE INVENTION [0001] 1. Field of the Invention [0002] The invention relates to heterologous gene expression. More particularly, the invention relates to the expression of microbial or parasitic organism genes in higher eukaryote cell systems. [0003] 2. Summary of the Related Art [0004] Recombinant production of certain heterologous gene products is often difficult in in vitro cell culture systems or in vivo recombinant production systems. For example, many researchers have found it difficult to express proteins derived from bacteria, parasites and virus in cell culture systems different from the cell from which the protein was originally derived, and particularly in mammalian cell culture systems. One example of a therapeutically important protein which has been difficult to produce by mammalian cells is the malaria merozoite surface protein (MSP-1). [0005] Malaria is a serious heath problem in tropical countries. Resistance to existing drugs is fast developing and a v...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(United States)
IPC IPC(8): A01K67/027A61K35/76A61K39/00A61K39/012A61K39/12A61K48/00C07H21/04C07K14/445C07K14/47C12N1/21C12N5/10C12N15/09C12N15/30C12N15/67C12N15/74C12N15/85C12P19/34
CPCA01K67/0275A61K48/00A01K2227/10A01K2227/105A01K2267/01A61K39/00A61K2039/51A61K2039/53C07K14/445C07K14/4732C07K2319/00C07K2319/02C12N15/67C12N15/8509C12N2830/008A01K2217/05Y02A50/30C12N15/11
Inventor CHEN, LIMEADE, HARRY
Owner CHEN LI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products